Time to fill in the pipeline survey!

SwedenBIO has for many years inventoried the R&D portfolio of Swedish pharmaceutical companies and presented the results in The Swedish Drug Discovery and Development Pipeline Report. Now, after a four-year break, it's back! The report is produced in collaboration with Business Sweden, Business Region Göteborg, Invest in Stockholm, Invest Skåne and Vinnova. Report release is planned for spring 2020.

Click on the link to participate: https://www.surveymonkey.com/r/pipeline2020

Why a report?
The report is a tool for SwedenBIO and our partners to promote Swedish life science globally and more specifically highlight Swedish companies active in pharmaceutical research and development. The report is also produced to provide a national overview of the industry and its needs in order to influence future investments in the life science sector where they are most needed.

Why participate?
Being included in the report gives the individual company global exposure. Through Business Sweden and regional investment promotion organizations, the report is disseminated globally and shared widely at international meetings. By completing the questionnaire, you ensure that accurate information about your company is presented in the report.

Who can participate?
All biotech and pharmaceutical companies with main operations and R&D activities in Sweden that have projects in the discovery, preclinical and/or clinical phase. Projects that have their regulatory affiliation in veterinary medicine or medical technology are not requested in this survey.

Questions?
Please contact Sara Gunnerås at sara.gunneras@swedenbio.se or 0730 40 87 00.